-
Agomelatine, sold
under the
brand names Valdoxan and Thymanax,
among others, is an
atypical antidepressant most
commonly used to
treat major depressive...
-
mixed evidence that
agomelatine, a 5-HT2C antagonist, is an
effective antidepressant.
Antagonism of 5-HT2C
receptors by
agomelatine results in an increase...
-
agomelatine which is
under development for the
treatment of mood and
anxiety disorders, for
instance generalized anxiety disorder. As an
agomelatine prodrug...
-
Health and Care
Excellence for
patients who fail
other treatment options.
Agomelatine, is a type of drug that acts on a dual melatonergic-serotonergic pathway...
- that of most
other antidepressants.
Atypical antidepressants include agomelatine, bupropion, iprindole, mianserin, mirtazapine, nefazodone, opipramol...
-
supplement in the
United States[citation needed] and Canada. In 2009
agomelatine (Valdoxan, Melitor, Thymanax) was also[clarification needed] approved...
- D-Phenylalanine (DPA, D-Phe; Deprenon, Sabiben, Sabiden) –
enkephalinase inhibitor Agomelatine (Valdoxan) – 5-HT2C
receptor antagonist and MT1 and MT2
receptor agonist...
-
disinhibit downstream norepinephrine and
dopamine release in the brain.
Agomelatine, an
antidepressant which disinhibits norepinephrine and
dopamine release...
-
Hydroxyzine (H1
receptor antagonist)
Vilazodone (atypical antidepressant)
Agomelatine (antidepressant, MT1/2
receptor agonist, 5-HT2C antagonist) Clonidine...
-
abnormally high
number of 5-HT2C
receptors in the
prefrontal cortex.
Agomelatine,
which is a 5-HT2C and 5-HT2B
antagonist as well as a MT1 and MT2 agonist...